Related Experiment Video
Updated: Aug 23, 2026

A Rat Model of Compound Acne
Published on: November 1, 2024
Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris
I Kurokawa1, S Nishijima, S Kawabata
1Department of Dermatology, Hyogo Prefectural Tsukaguchi Hospital, 6-8-17, Minamitsukaguchi-cho, Amagasaki, Hyogo 661-0012, Japan.
Abstract:
Systemic and topical antimicrobial treatment for acne vulgaris remains the mainstay method of therapy in Japan. Strains of Propionibacterium acnes (P. acnes) resistant to erythromycin (EM), clindamycin (CLDM), tetracycline (TC), doxycycline (DOXY) and minocycline (MINO) have been reported. The aim of the present study was to examine the antimicrobial susceptibility to 10 currently used antimicrobial agents of 50 strains of P. acnes isolated from acne lesions and identified using a Rap ID ANA II panel. Minimum inhibitory concentrations (MIC) were determined by the agar dilution method according to the criteria of the Japan Society of Chemotherapy. EM, ampicillin (ABPC), and CLDM were the most potent drugs, followed by MINO, nadifloxacin (NDFX), cephalexin (CEX), DOXY, ofloxacin (OFLX), and TC. In terms of the MIC80, EM and ABPC were the most potent, followed by CLDM, NDFX, MINO, CEX, DOXY, OFLX, TC and gentamycin (GM). Although most of the strains used were susceptible to the antimicrobial agents tested, strains of P. acnes resistant (MIC 12.5 mug/ml) to EM (4%), CLDM (4%), DOXY (2%) and TC (2%) were observed. In this study, no strains of P. acnes resistant to MINO were seen, suggesting that oral MINO is the most useful treatment for acne vulgaris with minimal risk of bacterial resistance.
Insights
Antimicrobial resistance in acne vulgaris is a growing concern. This study found Propionibacterium acnes strains resistant to erythromycin, clindamycin, doxycycline, and tetracycline, but not minocycline, suggesting its utility.
Area of Science:
- Microbiology
- Dermatology
- Pharmacology
Background:
- Systemic and topical antimicrobials are standard acne vulgaris treatments in Japan.
- Increasing antimicrobial resistance in Propionibacterium acnes (P. acnes) poses a therapeutic challenge.
Observation:
- This study evaluated the susceptibility of 50 P. acnes strains to 10 antimicrobial agents using the agar dilution method.
- Minimum Inhibitory Concentrations (MICs) were determined according to Japan Society of Chemotherapy criteria.
Findings:
- Erythromycin (EM), ampicillin (ABPC), and clindamycin (CLDM) showed the highest potency (MIC).
- EM and ABPC demonstrated the strongest MIC80 values, followed by CLDM, nadifloxacin (NDFX), minocycline (MINO), cephalexin (CEX), doxycycline (DOXY), ofloxacin (OFLX), tetracycline (TC), and gentamicin (GM).
- While most strains were susceptible, resistance was observed for EM (4%), CLDM (4%), DOXY (2%), and TC (2%). Notably, no P. acnes strains resistant to MINO were detected.
Implications:
- The emergence of resistant P. acnes strains necessitates careful selection of antimicrobial therapy.
- Minocycline (MINO) demonstrates significant efficacy against P. acnes, with minimal observed resistance, positioning it as a valuable treatment option for acne vulgaris.
Related Concept Videos
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antimicrobial Effectiveness
Bacterial Phylum Actinobacteria
The Skin Microbiota
Acne Infection
Clinical Significance of Antibiotic Resistance

